Brevan Howard Capital Management LP 89bio, Inc. Transaction History
Brevan Howard Capital Management LP
- $11 Billion
- Q2 2024
A detailed history of Brevan Howard Capital Management LP transactions in 89bio, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 24,000 shares of ETNB stock, worth $173,760. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,000
Previous 12,281
95.42%
Holding current value
$173,760
Previous $142,000
35.21%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ETNB
# of Institutions
157Shares Held
107MCall Options Held
65KPut Options Held
1.2M-
Ra Capital Management, L.P. Boston, MA14.2MShares$103 Million1.71% of portfolio
-
Janus Henderson Group PLC London, X013.3MShares$96.1 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.03MShares$58.2 Million2.69% of portfolio
-
Bvf Inc San Francisco, CA7.57MShares$54.8 Million1.85% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$53.4 Million0.99% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $337M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...